CELULARITY INC.

AMDAC

Medicinal and biological preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof, for pharmaceutical, clinical or medical laboratory use, namely, preparations that modulate the immune system; biological tissue from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof intended for use as a wound covering; wound dressings; burn dressing; surgical dressing; pharmaceutical preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof for the treatment and dressing of wounds; pharmaceutical preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof for use in preventing rejection of transplanted organs and tissue; and biological tissue intended for subsequent implantation, namely, blood, stem cells, umbilical cords and placentas, for medical and clinical use; biological preparations for medical purposes;genetic testing reagents for scientific laboratory use, namely, DNA probes; adhesives for biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific, laboratory and medical research;

AMDACS

Medicinal and biological preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof, for pharmaceutical, clinical or medical laboratory use, namely, preparations that modulate the immune system; biological tissue from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof intended for use as a wound covering; wound dressings; burn dressing; surgical dressing; pharmaceutical preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof for the treatment and dressing of wounds; pharmaceutical preparations from stem cells, stem cell tissue or stem cell scaffold, or a combination thereof for use in preventing rejection of transplanted organs and tissue; and biological tissue intended for subsequent implantation, namely, blood, stem cells, umbilical cords and placentas, for medical and clinical use; biological preparations for medical purposes;genetic testing reagents for scientific laboratory use, namely, DNA probes; adhesives for biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific, laboratory and medical research;

AUGMENTED IMMUNITY

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen;IMMUNITY;

AUGMENTED LONGEVITY

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen;

AUGMENTED VITALITY

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen;

BIOVANCE

biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds;

BIOVANCE

Amniotic membrane allograft; biological membrane for use in providing the extracellular matrix and repairing damaged tissue; biological membrane for use in repairing damaged tissue; biological membrane that serves as a natural scaffold; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds, ulcers and repairing damaged tissue;

CC CELULARITY

The mark consists of a purple tilted C next to a green backwards tilted C forming an infinity symbol above the word CELULARITY in purple.;Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen;The color(s) purple and green is/are claimed as a feature of the mark.;bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research;